In vivo molecular prediction of carbonic anhydrase IX-G250MN expression on immunotherapy outcome in renal cancer [1] (multiple letters)

Clinical Cancer Research

Volumn 11, Issue 24, 2005, Pages 8886-

  Brouwers, Adrienne H ^a   Boerman, Otto C ^b   Oyen, Wim J G ^b   Atkins, Michael B ^c  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c DANA FARBER HARVARD CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY G250; MONOCLONAL ANTIBODY MN75; UNCLASSIFIED DRUG;

CANCER IMMUNOTHERAPY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; ENZYME ANALYSIS; HUMAN; IMMUNOSCINTIGRAPHY; IN VIVO STUDY; KIDNEY CANCER; KIDNEY CARCINOMA; LETTER; NON INVASIVE PROCEDURE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

ANTIBODIES, MONOCLONAL; ANTIGENS, NEOPLASM; ANTINEOPLASTIC AGENTS; CARBONIC ANHYDRASES; HUMANS; INTERLEUKIN-12; KIDNEY NEOPLASMS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 29344463607     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-05-1512     Document Type: Letter

References (0)